Chengzhi Shareholding Co Ltd Asset Resilience Ratio
Chengzhi Shareholding Co Ltd asset resilience ratio. Chengzhi Shareholding Co Ltd (000990) has an Asset Resilience Ratio of 6.12% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Chengzhi Shareholding Co Ltd (000990) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Chengzhi Shareholding Co Ltd (2016–2025)
Asset resilience ratio of Chengzhi Shareholding Co Ltd from 2016 to 2025. This chart shows how Chengzhi Shareholding Co Ltd's Asset Resilience Ratio has changed over time. See free cash flow generation of Chengzhi Shareholding Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Chengzhi Shareholding Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Chengzhi Shareholding Co Ltd (000990) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.72 Billion | 6.12% |
| Total Liquid Assets | CN¥1.72 Billion | 6.12% |
Asset Resilience Insights
- Limited Liquidity: Chengzhi Shareholding Co Ltd maintains only 6.12% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Chengzhi Shareholding Co Ltd Industry Peers by Asset Resilience Ratio
Compare Chengzhi Shareholding Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND |
Biotechnology | 0.00% |
|
Verona Pharma plc
F:I9SA |
Biotechnology | 0.00% |
|
argenx NV ADR
NASDAQ:ARGX |
Biotechnology | 15.95% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND |
Biotechnology | 16.06% |
|
Achieve Life Sciences Inc
NASDAQ:ACHV |
Biotechnology | 3.60% |
|
Alpha Tau Medical Ltd
NASDAQ:DRTS |
Biotechnology | 65.79% |
|
Pulike Biological Engineering
SHG:603566 |
Biotechnology | 17.82% |
Chengzhi Shareholding Co Ltd Asset Resilience Ratio by Year (2016–2025)
Chengzhi Shareholding Co Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Chengzhi Shareholding Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.24% | CN¥1.73 Billion ≈ $253.84 Million |
CN¥27.79 Billion ≈ $4.07 Billion |
+1.17pp |
| 2024-12-31 | 5.07% | CN¥1.37 Billion ≈ $200.79 Million |
CN¥27.08 Billion ≈ $3.96 Billion |
-0.37pp |
| 2023-12-31 | 5.44% | CN¥1.40 Billion ≈ $204.87 Million |
CN¥25.74 Billion ≈ $3.77 Billion |
+3.29pp |
| 2022-12-31 | 2.15% | CN¥526.50 Million ≈ $77.04 Million |
CN¥24.53 Billion ≈ $3.59 Billion |
+12.83pp |
| 2021-12-31 | -10.69% | CN¥-2.61 Billion ≈ $-382.32 Million |
CN¥24.45 Billion ≈ $3.58 Billion |
-10.69pp |
| 2020-12-31 | 0.00% | CN¥275.00K ≈ $40.24K |
CN¥24.41 Billion ≈ $3.57 Billion |
+8.25pp |
| 2019-12-31 | -8.25% | CN¥-1.98 Billion ≈ $-290.41 Million |
CN¥24.06 Billion ≈ $3.52 Billion |
-15.79pp |
| 2018-12-31 | 7.54% | CN¥1.76 Billion ≈ $257.99 Million |
CN¥23.38 Billion ≈ $3.42 Billion |
-1.50pp |
| 2017-12-31 | 9.04% | CN¥1.90 Billion ≈ $278.03 Million |
CN¥21.02 Billion ≈ $3.08 Billion |
+7.86pp |
| 2016-12-31 | 1.18% | CN¥237.00 Million ≈ $34.68 Million |
CN¥20.15 Billion ≈ $2.95 Billion |
-- |
About Chengzhi Shareholding Co Ltd
Chengzhi Co., Ltd. engages in the clean energy, semiconductor display material, and healthcare and life science businesses in China. The company produces and sells gas products, including carbon monoxide, purified gas, and syngas, as well as industrial chemical products, such as methanol, ethylene, and butanol. It also processes materials comprising TN type, STN type, and TFT type; and glass proc… Read more